Collegium Pharmaceutical, Inc financial data

Symbol
COLL on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Technology Center Drive, Stoughton, Massachusetts
State of incorporation
Virginia
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 116 % +5.75%
Quick Ratio 6.86 % -31.6%
Debt-to-equity 452 % -13.4%
Return On Equity 49.1 %
Return On Assets 8.9 %
Operating Margin 35.3 % +105%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.2M shares -7.26%
Common Stock, Shares, Outstanding 32.3M shares -6.91%
Entity Public Float 742M USD +23.7%
Common Stock, Value, Issued 40K USD +5.26%
Weighted Average Number of Shares Outstanding, Basic 32.4M shares -6.32%
Weighted Average Number of Shares Outstanding, Diluted 40.4M shares -5.76%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 577M USD +7.4%
Research and Development Expense 7.04M USD -36%
Operating Income (Loss) 204M USD +120%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 141M USD +63.5%
Income Tax Expense (Benefit) 41.3M USD +719%
Net Income (Loss) Attributable to Parent 99.9M USD +50.7%
Earnings Per Share, Basic 3.06 USD/shares +57.9%
Earnings Per Share, Diluted 2.58 USD/shares +52.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 173M USD -39.1%
Marketable Securities, Current 98.7M USD +137%
Accounts Receivable, after Allowance for Credit Loss, Current 184M USD +9.78%
Inventory, Net 27.9M USD +7.05%
Other Assets, Current 93K USD +63.2%
Assets, Current 510M USD -5.04%
Deferred Income Tax Assets, Net 34.2M USD +38.9%
Property, Plant and Equipment, Net 15M USD -17%
Operating Lease, Right-of-Use Asset 5.59M USD -13.3%
Intangible Assets, Net (Excluding Goodwill) 353M USD -28.4%
Goodwill 134M USD 0%
Other Assets, Noncurrent 858K USD +1059%
Assets 1.05B USD -13.2%
Accounts Payable, Current 2.41M USD -0.33%
Employee-related Liabilities, Current 4.26M USD +146%
Accrued Liabilities, Current 38.7M USD +9.88%
Liabilities, Current 462M USD +6.13%
Deferred Income Tax Liabilities, Net 71.2M USD -24.7%
Operating Lease, Liability, Noncurrent 5.59M USD -15.6%
Liabilities 837M USD -17.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -182K USD -379%
Retained Earnings (Accumulated Deficit) -186M USD +35%
Stockholders' Equity Attributable to Parent 217M USD +7.86%
Liabilities and Equity 1.05B USD -13.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 61.9M USD +124%
Net Cash Provided by (Used in) Financing Activities -54.1M USD -179%
Net Cash Provided by (Used in) Investing Activities -18.1M USD -10200%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 39.5M shares +4.16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 174M USD -38.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 17.5M USD -10.4%
Deferred Tax Assets, Valuation Allowance 5.78M USD +10%
Deferred Tax Assets, Gross 103M USD -16.6%
Operating Lease, Liability 7.11M USD -13.5%
Depreciation 917K USD +12.2%
Payments to Acquire Property, Plant, and Equipment 568K USD +223%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 99.7M USD +50.7%
Lessee, Operating Lease, Liability, to be Paid 8.49M USD -15.7%
Property, Plant and Equipment, Gross 25.7M USD -0.71%
Operating Lease, Liability, Current 1.04M USD +6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.44M USD +2.72%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.4M USD -11.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) -4.41M USD -9491%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.38M USD -25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.47M USD +2.65%
Deferred Tax Assets, Operating Loss Carryforwards 33.8M USD -40.7%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 11.3M USD -0.83%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.49M USD +1.02%
Additional Paid in Capital 568M USD +3.55%
Amortization of Intangible Assets 34.5M USD -7.87%
Deferred Tax Assets, Net of Valuation Allowance 97.4M USD -17.8%
Share-based Payment Arrangement, Expense 31.5M USD +30.5%
Interest Expense 79.3M USD +0.56%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%